Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
28
NCT00897130
5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)
Phase: Phase 2
Role: Collaborator
Start: Aug 31, 2008
Completion: Dec 31, 2014